Thrombolytic therapy for elderly patients
- PMID: 1598101
- DOI: 10.1056/NEJM199207023270109
Thrombolytic therapy for elderly patients
Comment in
-
The risk of stroke after thrombolytic therapy.N Engl J Med. 1992 Nov 19;327(21):1531-2. doi: 10.1056/NEJM199211193272116. N Engl J Med. 1992. PMID: 1406889 No abstract available.
Comment on
-
The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.N Engl J Med. 1992 Jul 2;327(1):1-6. doi: 10.1056/NEJM199207023270101. N Engl J Med. 1992. PMID: 1598096 Clinical Trial.
-
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.N Engl J Med. 1992 Jul 2;327(1):7-13. doi: 10.1056/NEJM199207023270102. N Engl J Med. 1992. PMID: 1598117
Similar articles
-
Safe use of thrombolysis in the elderly.Geriatrics. 1989 Nov;44(11):28-30, 33-6. Geriatrics. 1989. PMID: 2509296 Review.
-
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.N Engl J Med. 1992 Jul 2;327(1):7-13. doi: 10.1056/NEJM199207023270102. N Engl J Med. 1992. PMID: 1598117
-
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.N Engl J Med. 1995 May 25;332(21):1418-24. doi: 10.1056/NEJM199505253322106. N Engl J Med. 1995. PMID: 7723799
-
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.Am J Cardiol. 1993 May 1;71(12):1127-30. doi: 10.1016/0002-9149(93)90591-y. Am J Cardiol. 1993. PMID: 8475887 Clinical Trial. No abstract available.
-
Stroke associated with thrombolytic therapy for acute myocardial infarction.Heart Dis Stroke. 1992 Sep-Oct;1(5):287-94. Heart Dis Stroke. 1992. PMID: 1344119 Review. No abstract available.
Cited by
-
Fibrinolytic treatment for elderly patients with acute myocardial infarction.Heart. 2002 Apr;87(4):308-11. doi: 10.1136/heart.87.4.308. Heart. 2002. PMID: 11906993 Free PMC article. No abstract available.
-
In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry.Clin Cardiol. 2000 Nov;23(11):831-6. doi: 10.1002/clc.4960231109. Clin Cardiol. 2000. PMID: 11097130 Free PMC article.
-
Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates.J Thromb Thrombolysis. 2002 Feb;13(1):21-6. doi: 10.1023/a:1015312007648. J Thromb Thrombolysis. 2002. PMID: 11994556
-
The effect of reduction of door-to-needle times on the administration of thrombolytic therapy for acute myocardial infarction.Postgrad Med J. 1998 Sep;74(875):533-6. doi: 10.1136/pgmj.74.875.533. Postgrad Med J. 1998. PMID: 10211326 Free PMC article.
-
Coronary artery disease, valvular heart disease, bradycardia, and heart failure.Postgrad Med J. 1995 Jun;71(836):346-53. doi: 10.1136/pgmj.71.836.346. Postgrad Med J. 1995. PMID: 7644396 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical